In terms of the CD4+ T cell subset, peripheral CD4+ T cells are also implicated in mediating antitumor immunity when treated with anti-CTLA-4 antibodies, either from mouse models or patients with metastatic melanoma.225. The gene discussed is CD4; the disease is metastatic melanoma.